AsOf

Gilead Sciences · subsidiaryKite Pharma

valid: Two independent sources agree, or a primary source states it: the record asserts this claim.asserted

What the statuses mean

Valid from
undated
Valid until
still holds
Published
2018-02-27
Recorded by AsOf
2026-11-08
Checked
2026-11-10 · its source page states the value and the date
Confidence
0.80

Sources

“On October 3, 2017 (the Acquisition Date), we completed a tender offer for all of the outstanding common stock of Kite Pharma, Inc. (Kite) for $180 per share in cash. As a result, Kite became our wholly-owned subsidiary.”— what the page says, read 2026-11-10

Cite this claim

Each form names the value, its as-of date, the day you read it (2026-11-11), the claim's stable URL and id and its primary source. The URL never changes: a superseded claim stays at the same address.

Plain text
AsOf. "Gilead Sciences subsidiary: Kite Pharma", undated. Claim clm_B6ADB7E79288, https://asof.is/claim/clm_B6ADB7E79288, accessed 2026-11-11. Source: https://www.sec.gov/Archives/edgar/data/882095/000088209518000008/a2017form10-k.htm.
APA
AsOf. (n.d.). Gilead Sciences subsidiary: Kite Pharma (undated) [Record clm_B6ADB7E79288]. Retrieved November 11, 2026, from https://asof.is/claim/clm_B6ADB7E79288 (source: https://www.sec.gov/Archives/edgar/data/882095/000088209518000008/a2017form10-k.htm)
BibTeX
@misc{asof_clm_B6ADB7E79288,
  author = {AsOf},
  title = {Gilead Sciences subsidiary: Kite Pharma},
  howpublished = {\url{https://asof.is/claim/clm_B6ADB7E79288}},
  note = {Claim clm\_B6ADB7E79288, undated; source: https://www.sec.gov/Archives/edgar/data/882095/000088209518000008/a2017form10-k.htm},
  urldate = {2026-11-11}
}

On the record

/claim/clm_B6ADB7E79288.md/v1/claims/clm_B6ADB7E79288submit a correction